DOI QR코드

DOI QR Code

Colon Cancer Screening-Is It Necessary to Start under the Age of 50?

대장암 검진-50세 이하부터 시작하는 것은 필요한 것인가?

  • Jongbeom Shin (Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine)
  • 신종범 (인하대학교 의과대학 인하대병원 내과학교실)
  • Received : 2023.11.01
  • Accepted : 2023.12.11
  • Published : 2023.12.20

Abstract

Colorectal cancer is the third most common cancer worldwide. The occurrence of colon cancer can be prevented by removing precursor lesions. Several countries are making efforts to prevent the occurrence of colon cancer via screening programs. Korea is also following suite by screening individuals < 50 years of age. Currently, the incidence of colon cancer among the young is increasing globally, and Korea has a high colon cancer incidence rate among individuals in their 20s and 40s. Therefore, it may be necessary to start the screening individuals < 50 years of age to detect the cancer's manifestation early. Moreover, advanced adenomas associated with poor prognosis can be detected early, the overall screening rate can be increased, and death from colon cancer at a young age can be prevented. Although the period of colorectal cancer screening has been expanded, the overall colorectal cancer screening rate has not. Additionally, increasing the screening rate among individuals > 50 years could reduce the mortality rate at a lower cost. Although the incidence of colon cancer is increasing in younger individuals, the evidence to conclude that screening at the age of < 50 years has a meaningful impact on the incidence and survival rates of colon cancer remains insufficient. Therefore, rather than following the trend and performing screening early, an approach that actively selects cases where tests for colorectal cancer diagnosis are required is warranted.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2021R1G1A1095241) and by Inha University Research Grant.

References

  1. Sinicrope FA. Increasing incidence of early-onset colorectal cancer. N Engl J Med 2022;386:1547-1558. https://doi.org/10.1056/NEJMra2200869 
  2. Oh SY, Lee JH, Kim HJ. Analyses on the factors associated with dietary behavior regarding colon cancer risk. J Nutr Health 2004;37:202-209. 
  3. Pak S, Jung KW, Park EH, Ko YH, Won YJ, Joung JY. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer. Investig Clin Urol 2022;63:175-183. https://doi.org/10.4111/icu.20210405 
  4. Itzkowitz SH, Ahlquist DA. Colorectal adenomas. N Engl J Med 2016;375:388-389. https://doi.org/10.1056/NEJMc1604867 
  5. Suh M, Song S, Cho HN, et al. Trends in participation rates for the national cancer screening program in Korea, 2002-2012. Cancer Res Treat 2017;49:798-806. https://doi.org/10.4143/crt.2016.186 
  6. Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. Early-onset colorectal cancer in young individuals. Mol Oncol 2019;13:109-131. https://doi.org/10.1002/1878-0261.12417 
  7. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol 2022;7:262-274. https://doi.org/10.1016/S2468-1253(21)00426-X 
  8. Feng H, Lyu Z, Zheng J, et al. Association of tumor size with prognosis in colon cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Surgery 2021;169:1116-1123. https://doi.org/10.1016/j.surg.2020.11.011 
  9. Nam JS. National cancer screening program. J Korean Med Assoc 2010;53:386-391.  https://doi.org/10.5124/jkma.2010.53.5.386
  10. Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol 2021;116:458-479. https://doi.org/10.14309/ajg.0000000000001122 
  11. Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Publications Office of the European Union, 2010. 
  12. Saito Y, Oka S, Kawamura T, et al. Colonoscopy screening and surveillance guidelines. Dig Endosc 2021;33:486-519. https://doi.org/10.1111/den.13972 
  13. Fedewa SA, Siegel RL, Goding Sauer A, Bandi P, Jemal A. Colorectal cancer screening patterns after the American Cancer Society's recommendation to initiate screening at age 45 years. Cancer 2020;126:1351-1353. https:// doi.org/10.1002/cncr.32662 
  14. Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Ann Oncol 2018;29:1016-1022. https://doi.org/10.1093/annonc/mdy033 
  15. Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 2015;150:17-22. https://doi.org/10.1001/jamasurg.2014.1756 Erratum in: JAMA Surg 2015;150:277. https://doi.org/10.1001/jamasurg.2015.156 
  16. Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019;68:1820-1826. https://doi.org/10.1136/gutjnl-2018-317592 
  17. Young JP, Win AK, Rosty C, et al. Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol 2015; 30:6-13. https://doi.org/10.1111/jgh.12792 
  18. Sandhu GS, Anders R, Blatchford P, et al. High incidence of prolonged rectal bleeding and advanced stage cancer in early-onset colorectal cancer patients. Colorectal Cancer 2020;9:CRC31. https://doi.org/10.2217/crc-2020-0012 
  19. Chen FW, Sundaram V, Chew TA, Ladabaum U. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol 2017;15:728-737.e3. https://doi.org/10.1016/j.cgh.2016.10.038 
  20. Patel SG, Ahnen DJ. Colorectal cancer in the young. Curr Gastroenterol Rep 2018;20:15. https://doi.org/10.1007/s11894-018-0618-9 
  21. Ballester V, Rashtak S, Boardman L. Clinical and molecular features of young-onset colorectal cancer. World J Gastroenterol 2016;22:1736-1744. https://doi.org/10.3748/wjg.v22.i5.1736 
  22. Lee J, Kim IH, Kim JS, et al. Different clinical characteristics in sporadic young-age onset colorectal cancer. Medicine (Baltimore) 2016;95:e4840. https://doi.org/10.1097/MD.0000000000004840 
  23. Oh JW, Huh JW, Park YA, et al. Clinicopathologic characteristics of patients with sporadic colorectal cancer under the age of 30. Korean J Clin Oncol 2016;12:67-72. https://doi.org/10.14216/kjco.16011 
  24. Jacobs D, Zhu R, Luo J, et al. Defining early-onset colon and rectal cancers. Front Oncol 2018;8:504. https://doi.org/10.3389/fonc.2018.00504 
  25. Ladabaum U, Mannalithara A, Meester RGS, Gupta S, Schoen RE. Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology 2019;157:137-148. https://doi.org/10.1053/j.gastro.2019.03.023 
  26. Kang HT. Current status of the national health screening programs in South Korea. Korean J Fam Med 2022;43:168-173. https://doi.org/10.4082/kjfm.22.0052 
  27. Liu PH, Singal AG, Murphy CC. No increase in colorectal cancer screening in 2019 after American Cancer Society recommends starting screening at age 45. Clin Gastroenterol Hepatol 2023;21:1947-1949.e2. https://doi.org/10.1016/j.cgh.2022.05.030